Immunoadsorption Devices Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

Rising number of cases related to cardiology, neurology, dermatology, kidney, and transplant owing to changing people lifestyle, growing geriatric population, and pollution is boosting the demand of immunoadsorption devices. These devices are used in disease such as dilated cardiomyopathy, myocardial infarction, chagas cardiomyopathy, hyperlipidemia, multiple sclerosis, Guillain-Barre syndrome, autoimmune encephalitis, chronic inflammatory demyelinating polyradiculopathy, dementia, Lambert-Eaton myasthenic syndrome. Further, with the advancement in the sector, the immunoadsorption device is finding new application areas such as sepsis.

Request To Download Sample of this Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=18787

Immunoadsorption is an extracorporeal technique used for the removal of specific blood group antibodies and molecules from the blood. Currently, a large and different number of devices or columns each with a different active component to which the molecule of interest attaches, thereby allowing for selectivity in the molecules removed. The ability to select a different type of device for different conditions makes the immunoadsorption’s significant advantages over other apheresis techniques, in that it negates the need for replacement of factors such as albumin and plasma. For instance, Pocard’s Toxipak is a selective immunoadsorption device used in sepsis and sepsis shock where another selective immunoadsorption device Gylcosorb ABO is used in ABO compatibility.

According to UnivDatos Market Insights (UMI)’ research report “Global Immunoadsorption Devices Market”, the market is expected to showcase significant growth during the forecast period 2021-2027F. Rising autoimmune and transplantation cases and growing geriatric population are some of the key attributable factors for the growth of the market

Based on type, the market is categorized into selective, semi-selective, non-selective, and others. Among these, selective category held the considerable market share and is expected to continue its performance during the forecast period. This can be attributed to the presence of large number of immunoadsorption devices like Toxipak, Pentrasorb CRP, Miro, Glycosorb ABO, ABO Adsopak, Coraffin, IgEnio, DALI, Monet, and LDL lipopak. Further, selective immunoadsorption device helps in selectively target the molecules without disturbing other molecules, thereby it is commonly used in autoimmune conditions and transplantation.

Request To Download Sample of this Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=18787

Based on therapeutic area, the market is categorized into cardiology, neurology, transplant, kidney, and others. Among these, cardiology held the considerable share in the market owing to large number of cardiovascular cases. According to World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally. In 2019, representing 32% of all global deaths. Further, increasing geriatric population and changing lifestyle is likely to increase the case in the foreseeable future. This in turn is expected to propel the demand of immunoadsorption devices.

North America accounted for the significant share in the Immunoadsorption Devices market

North America accounted for the significant share in the market and is expected to showcase significant growth during the forecast period. This can be attributed to the large investment in medical device industry couple with high and early adoption of new medical devices among healthcare provider and patient. Further, a large number of population in the region is covered under health insurance schemes which help the people of the region to treat the disease with best possible available treatment. In addition, stringent government regulations in the approval of products creates strong barrier to substitutes, this in turn aids in the growth of immunoadsorption devices. Further, growing population and fast-forward lifestyle resulted in larger number of chronic diseases. For instance, heart disease costs the United States about $363 billion each year from 2016 to 2017. This includes the cost of health care services, medicines, and lost productivity due to death.  Thereby, creating demand of medical devices including immunoadsorption devices.

For more informative information, please visit us – https://univdatos.com/report/immunoadsorption-devices-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the global immunoadsorption devices market include Pocard Ltd., Pentracor GmbH, Glycorex Transplantation AB, Fresenius Medical Care, Asahi Kasei Medical Device, Miltenyi Biotec, Kaneka Medical Product, Baxter International Inc., CytoSorbents Europe GmbH, and Toray Medical Co. Ltd. These companies are taking several strategic decisions to meet the growing demand and increase their market share.  For instance,

·        In June 2019, Toray Medical Co. Ltd., announced that a small size of TORAYMYXIN (PMX-05R) had obtained EC certificate and is launched in the EU market. TORAYMYXIN is indicated for use in the treatment of patients with sepsis or septic shock caused by gram-negative bacteria. The small size had been developed for patients with low body weight, who may not have enough blood volume to perform blood purification therapy with a regular size of TORAYMYXIN (PMX-20R).

“Global Immunoadsorption Devices Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on different parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.      

For more informative information, please visit us – https://univdatos.com/report/immunoadsorption-devices-market/

Market Segmentation:

1.      By Type (Selective, Semi-Selective, Non-Selective, and Others)

2.      By Product (Toxipak, Pentrasorb CRP, Glycosorb ABO, IgEnio, DALI, Monet, Immunsorba TR, Immunsorba, Therasorb, Selesorb, Oxiris, Cytosorb, Toraymyxin, Seraph, Alteco LPS Adsorber, and others)

3.      By Therapeutic Area (Cardiology, Neurology, Transplant, Kidney, and Others)

4.      By Region (North America (US, Canada, Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), and Rest of World)

5.      By Company (Pocard Ltd., Pentracor GmbH, Glycorex Transplantation AB, Fresenius Medical Care, Asahi Kasei Medical Device, Miltenyi Biotec, Kaneka Medical Product, Baxter International Inc., CytoSorbents Europe GmbH, and Toray Medical Co. Ltd.)

Key questions answered in the study:

1.      What are the current and future trends of the global Immunoadsorption Devices industry?

2.      How the industry has been evolving in terms of type, product, and therapeutic area?

3.      How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.      What are the key growth drivers and challenges for the global Immunoadsorption Devices industry?

5.     What are the customer orientation, purchase behavior, and expectations from the global Immunoadsorption Devices suppliers across various region and countries?

 

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL IMMUNOADSORPTION DEVICES MARKET COVID-19 IMPACT

6 GLOBAL IMMUNOADSORPTION DEVICES MARKET REVENUE (USD MN), 2019-2027F

7 MARKET INSIGHTS BY TYPE

8 MARKET INSIGHTS BY PRODUCT

9 MARKET INSIGHTS BY THERAPEUTIC AREA

10 MARKET INSIGHTS BY REGION

11 IMMUNOADSORPTION DEVICES MARKET DYNAMICS

12 IMMUNOADSORPTION DEVICES MARKET OPPORTUNITIES

13 IMMUNOADSORPTION DEVICES MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

18 COMPANY PROFILED

19 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·        3D Printed Drugs Market to Reach US$ 2,064.8 Million by 2027 Globally | CAGR: 15.2% |

·        Gene Therapy Market to Reach US$ 20.9 Billion by 2027, Globally |CAGR: 29.7%|

·        Healthcare Cloud Computing Market to Reach US$ 80.5 Billion by 2027 Globally |CAGR: 14.5%| 

·        Virtual Healthcare Delivery Market to Reach US$ 122 Billion by 2027 Globally |CAGR: 24.6%|